Amparo Benito

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

M. Duruisseaux, Anna Martínez‐Cardús, María Eréndira Calleja-Cervantes et al. · The Lancet Respiratory Medicine · 2018 · 222 citations · Full text

Medicine, Oncology, Epigenetics +16

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

Esther Conde, Susana Hernández, Rebeca Martínez et al. · Journal of Thoracic Oncology · 2019 · 73 citations · Full text

Medicine, Molecular Biology, Oncology +17

Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry

Esther Conde, Ana Suárez‐Gauthier, Amparo Benito et al. · PLoS ONE · 2014 · 65 citations · Full text

Medicine, Cancer Biology, Oncology +17

Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy

Ricardo Hitt, Eva Ciruelos, María L. Amador et al. · European Journal of Cancer · 2004 · 63 citations

Medicine, Oncology, Chemotherapy +5

Canakinumab with and Without Pembrolizumab in Patients with Resectable Non-Small-Cell Lung Cancer: CANOPY-N Study Design

Pilar Garrido, Jean-Louis Pujol, Edward S. Kim et al. · Future Oncology · 2021 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17